This updated Medicines Q&A evaluates the limited evidence available for low dose naltrexone for treatment of multiple sclerosis.
Attachments
- UKMI_QA_LDNfor-MS_Feb_2020 · PDF · 177 KB
This updated Medicines Q&A evaluates the limited evidence available for low dose naltrexone for treatment of multiple sclerosis.